S
Seer
Focused on capturing and translating proteome insights to advance human health
About Seer
Seer is a biotechnology company that has developed a platform for proteomics, the large-scale study of proteins. The company's flagship product, the Proteograph, is a platform that enables researchers to conduct deep, unbiased, and rapid analysis of the proteome.
Read full description
Seer's technology is designed to provide a more comprehensive view of the proteome than was previously possible. This is achieved through a combination of proprietary nanoparticles and software that allows for the selective capture and analysis of proteins from complex biological samples. The company's platform is used by researchers in a variety of fields, including drug discovery, diagnostics, and basic research.
Seer's business model is based on the sale of its Proteograph platform, as well as recurring revenue from the sale of consumables and software. The company's customers include academic and government research institutions, as well as pharmaceutical and biotechnology companies. Seer is a publicly traded company, listed on the Nasdaq stock exchange under the ticker symbol SEER.
At a glance
- Founded
- 2017
- Headquarters
- Redwood City, United States
- Listing
- IPO 2020
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Maverick Ventures
Invus
Series B and later5 investors entered at this stage
Wing Venture Capital
Aju IB Investment
aMoon Fund
Fidelity Investments
T. Rowe Price
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
39 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Seer on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Seer on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.